UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023676
Receipt number R000027268
Scientific Title Intravitreal anti-VEGF therapies for macular edema folowing age-related macular degeneration
Date of disclosure of the study information 2016/09/01
Last modified on 2023/07/28 11:07:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intravitreal anti-VEGF therapies for macular edema folowing age-related macular degeneration

Acronym

Intravitreal anti-VEGF therapy for AMD

Scientific Title

Intravitreal anti-VEGF therapies for macular edema folowing age-related macular degeneration

Scientific Title:Acronym

Intravitreal anti-VEGF therapy for AMD

Region

Japan


Condition

Condition

age-related macular degeneration

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine outcomes of patients with anti-vasucular endthelial factor antibody-treated age-related macular degeneration.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

visual acuity

Key secondary outcomes

intraocular pressure, central retinal thickness, subfoveal choroidal thickness, nAMD subtype, drusen subtype, recurrence of macular edema, smoking history, medical history (high blood pressure, diabetes, cerebral infarction, myocardial infarction), Plasma catecholamines level


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patinets with age-related macular degeneration

Key exclusion criteria

none

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Kamao

Organization

Kawasaki Medical School

Division name

Department of Ophthalmology

Zip code

701-0114

Address

Kurashiki

TEL

086-462-1111

Email

hironeri@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Kamao

Organization

Kawasaki Medical School

Division name

Department of Ophthalmology

Zip code

701-0114

Address

Kurashiki

TEL

086-462-1111

Homepage URL

https://m.kawasaki-m.ac.jp/kenkyu/rinri/kadai/kadai40.php

Email

hironeri@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Kawasaki Medical School

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawasaki Medical School

Address

Kurashiki Matsushima 577

Tel

086-462-1111

Email

hironeri@med.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 08 Month 16 Day

Date of IRB

2016 Year 11 Month 14 Day

Anticipated trial start date

2016 Year 11 Month 14 Day

Last follow-up date

2031 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective study, non-intervention, non-invasive


Management information

Registered date

2016 Year 08 Month 18 Day

Last modified on

2023 Year 07 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027268


Research Plan
Registered date File name
2017/07/05 研究実施計画書.doc

Research case data specifications
Registered date File name
2017/07/05 AMD 症例データ仕様書.xlsx

Research case data
Registered date File name
2023/02/27 Low data.xlsx